10/29/2012 – Lilly trials boost amyloid link to Alzheimer's-analysis

Oct 31, 2012 Comments Off by

Levels of a protein believed to be a main cause of Alzheimer’s disease rose in the blood of patients treated with Eli Lilly’s experimental drug in late-stage trials, suggesting the protein, beta amyloid, was removed from the brain as intended, researchers said on Monday.

Read the full article at Reuters.

Longevity News 2012, mind

About the author

The author didnt add any Information to his profile yet